SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Snead MP, Rubinstein MP, Jacobs PM. The optics of fundus examination. Surv Ophthalmol 1992; 36: 43945
  • 2
    Hubbard LD, Brothers RJ, King WN et al. Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. Ophthalmology 1999; 106: 226980
  • 3
    Burchardt M, Burchardt T, Anastasiadis AG et al. Erectile dysfunction is a marker for cardiovascular complications and psychological functioning in men with hypertension. Int J Impot Res 2001; 13: 27681
  • 4
    Hyman BN. The eye as a target organ: an updated classification of hypertensive retinopathy. J Clin Hypertens 2000; 2: 1947
  • 5
    Cuspidi C, Macca G, Salerno M et al. Evaluation of target organ damage in arterial hypertension: which role for qualitative funduscopic examination? Ital Heart J 2001; 2: 7026
  • 6
    Fuchs FD, Maestri MK, Bredemeier M et al. Study of the usefulness of optic fundi examination of patients with hypertension in a clinical setting. J Hum Hypertens 1995; 9: 54751
  • 7
    Dodson PM, Lip GY, Eames SM, Gibson JM, Beevers DG. Hypertensive retinopathy: a review of existing classification systems and a suggestion for a simplified grading system. J Hum Hypertens 1996; 10: 938
  • 8
    Stanton AV, Wasan B, Cerutti A et al. Vascular network changes in the retina with age and hypertension. J Hypertens 1995; 13: 17248
  • 9
    Stanton AV, Mullaney P, Mee F, O'Brien ET, O'Malley K. A method of quantifying retinal microvascular alterations associated with blood pressure and age. J Hypertens 1995; 13: 418
  • 10
    Pellegrino L, Prencipe G, Ferrara V, Correra M, Pellegrino PL. 2D Echo color-Doppler study of the extracranial carotid arteries in borderline arterial isolated systolic hypertension. Minerva Cardioangiol 2002; 50: 914
  • 11
    Pearson TA. New tools for coronary risk assessment. what are their advantages and limitations? Circulation 2002; 105: 88692
  • 12
    Conti CR, Pepine CJ, Sweeney M. Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease. Am J Cardiol 1999; 83: 29C34C
  • 13
    Kloner RA, Jarow JP. Erectile dysfunction and sildenafil citrate and cardiologists. Am J Cardiol 1999; 83: 57682
  • 14
    Wespes E, Raviv G, Vanegas JP et al. Corporeal veno-occlusive dysfunction: a dorsal arterial pathology? J Urol 1998; 160: 20547
  • 15
    Yamazaki M. The relative assessment of atherosclerosis in vessels of major organs and its factors for progression. Nippon Ronen Igakkai Zasshi 1993; 30: 80716
  • 16
    Bernardczykowa A, Zawilski J. Fundus oculi changes in chronic ischemia of the lower extremities. Klin Oczna 1991; 93: 2912
  • 17
    Miettinen H, Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Retinopathy predicts coronary heart disease events in NIDDM patients. Diabetes Care 1996; 19: 14458
  • 18
    Wong TY, Klein R, Klein BE, Tielsch JM, Hubbard L, Nieto FJ. Retinal microvascular abnormalities and their relationship with hypertension, cardiovascular disease, and mortality. Surv Ophthalmol 2001; 46: 5980
  • 19
    Greenstein A, Chen J, Miller H, Matzkin H, Villa Y, Braf Z. Does severity of ischemic coronary disease correlate with erectile function? Int J Impot Res 1997; 9: 1236
  • 20
    Kawanishi Y, Lee KS, Kimura K et al. Screening of ischemic heart disease with cavernous artery blood flow in erectile dysfunctional patients. Int J Impot Res 2001; 13: 1003
  • 21
    Qureshi AI, Suri MF, Mohammad Y, Guterman LR, Hopkins LN. Isolated and borderline isolated systolic hypertension relative to long-term risk and type of stroke: a 20-year follow-up of the national health and nutrition survey. Stroke 2002; 33: 27818
  • 22
    Marumo K, Murai M. Effects of hypertension and antihypertensive drugs on sexual function in elderly men. Jpn J Impotence Res 2000; 15: 36771
  • 23
    Gonzalez CM, Bervig T, Podlasek C, Huang CF, McKenna KE, McVary KT. Sildenafil causes a dose- and time-dependent downregulation of phosphodiesterase type 6 expression in the rat retina. Int J Impot Res Supplement 1999; 1: S914
  • 24
    Behn D, Potter MJ. Sildenafil-mediated reduction in retinal function in heterozygous mice lacking the gamma-subunit of phosphodiesterase. Invest Ophthalmol Vis Sci 2001; 42: 5237